According to the new market research report "Research Antibodies and Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blotting, Flow Cytometry), Application (Proteomics, Drug Development), End User - COVID-19 Impact - Global Forecast to 2025", published by MarketsandMarkets™, the global market size is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period.
The growth is due to evolution of market owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and increasing R&D activity and expenditure in the life sciences industry. Fueled by the growing demand for personalized medicine and structure-based drug design, the global market is expected to witness significant growth in the coming years. Browse in-depth TOC on "Research Antibodies and Reagents Market" 220 – Tables 45 – Figures 278 – Pages Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793 The COVID-19 outbreak has boosted research activity due to efforts to understand the dynamics of the infection. We estimate that the major share of research antibody and reagent manufacturing, along with personalized medicine, will grow at a stable pace in the next five years. Due to the increase in research activity, both the availability of funding for research and the demand & manufacturing of reagents and antibodies are expected to grow. As companies after pandemic have scaled up their operations for testing and tracking the infection of COVID-19. This has given a chance for growth in profits for companies operating in the NGS and PCR markets. The growth in revenue is 5–7%, as COVID-19 testing has increased with the use of the latest technology of genetic and molecular testing. The shift in demand for research for COVID-19, neurobiology, and oncology has created a huge scope for testing solutions, such as western blotting, flow cytometry, ELISA, and drugs for researchers and laboratories. The antibodies segment is expected to grow at the highest CAGR during the forecast period Based on product, the research antibodies market is segmented into reagents and antibodies. The antibodies segment is expected to grow at highest CAGR in forecast period. This is due to the research-use antibodies offer high specificity and selectivity and are used ubiquitously in biochemical and medical research for protein-target identification, regulatory characterization, and discovery. The primary antibodies segment is accounts for the largest share of the research reagents market Based type, the research reagents market is segmented into primary antibodies and secondary antibodies. The primary antibodies segment held the largest share of the global research antibodies market in 2019. This segment is witnessing a strong growth due to the use of these antibodies in numerous types of assay formats. Their accuracy in biomarker detection and their high specificity and sensitivity are also driving their adoption The media & sera reagent is expected to account for the largest share of the market, by type, in 2019 Based type, the research antibodies and reagents market is segmented into media &sera, stains & dyes, fixatives, buffers, solvents, enzymes, probes and other reagents. The media & sera reagent segment held the largest share of the global research antibodies market in 2019. The large share of this segment is primarily attributed to the use of these components in all types of assays, cell cultures, and techniques. The western blotting segment is expected to account for the largest share of the market, by technology, in 2019 Based on technology, the research antibodies market is segmented into western blotting, flow cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and other technologies. Western blotting segment is expected to grow at highest CAGR in forecast periods (2020-2025). This is due to the high adoption of this technique in proteomic and genomic research. The results achieved are easy to interpret, unique, and unambiguous, making it suited for evaluating levels of protein expression in cells, monitoring fractions during protein purification, and comparing the expression of a target protein from various tissues. The pharmaceutical & biotechnology segment is expected to grow at the highest CAGR during the forecast period Based on end user, the research reagents market is segmented into the pharmaceutical & biotechnology companies, academic & research institutions and Contract Research Organizations. The growth of this segment is due to antibodies provide a gold standard for the detection of a biomolecule or a pathway and are even capable of detecting specific changes in potential drug targets. Additionally, highly specific reagents are used to measure pharmacokinetic parameters in the preclinical and clinical development of biological drugs. The increasing demand for personalized medicine and government initiatives in this sector are the key market drivers for this segment. Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION:-https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=94212793 The APAC market is expected to grow at the highest CAGR during the forecast period The Asia Pacific research reagents market is expected to grow at the highest CAGR from 2020 to 2025.The growth of this market is primarily due to growing proteomics and genomics research and increasing research funding, investments by pharmaceutical and biotechnology companies, and growing awareness of personalized therapeutics in the region. Also, high-growth countries, such as China, India, Japan, South Korea, Taiwan, Australia, and Singapore are the major contributors to the Asia Pacific research antibodies and reagents market. This region is expected to grow at the highest pace during the forecast period primarily due to growing proteomics and genomics research and increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and growing awareness about personalized therapeutics. The prominent market players are Thermo Fisher Scientific (US), Merck Group (Germany), Abcam plc (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), and BioLegend (US). Browse Related Reports: Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents, Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Laboratories, Pharma-Biotech Cos), Application - Global Forecasts to 2025 https://www.marketsandmarkets.com/Market-Reports/flow-cytometry-market-65374584.html
0 Comments
According to the new market research report "Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food producing & Companion) - Global Forecast to 2026", published by MarketsandMarkets™, the global Animal Antimicrobials Market is projected to reach USD 5.6 billion by 2026 from USD 4.7 billion in 2021, at a CAGR of 3.6% from 2021 to 2026.
Browse in-depth TOC on "Animal Antibiotics and Antimicrobials Market" 151 – Tables 35 – Figures 152 – Pages Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=25161353 The animal antibiotics market growth can largely be attributed to the rising demand for animal-derived food products, increasing incidence of zoonotic diseases, and the implementation of regulations to prevent the spread of animal diseases. Rising animal healthcare spending and the growing demand for pet insurance are further expected to drive the growth of this market. The untapped emerging markets such as China, India, and Brazil and growth in the overall companion animal population are also expected to offer significant growth opportunities to market players in the coming years. However, the limited number of new antibiotics, growing resistance to antimicrobials and antibiotics, and increasing good husbandry and hygiene practices are expected to hinder the growth of this market to a certain extent. The Tetracyclines segment accounted for the largest market share in 2020. Based on products, the global animal antimicrobials and antibiotics market is segmented into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobial and antibiotic products. In 2020, the tetracyclines segment accounted for 48.9% of the global animal antimicrobials market. Tetracyclines exhibit advantages such as the highest potency against pathogenic microorganisms, are well-absorbed, show low toxicity, and are relatively inexpensive compared to other animal antimicrobial and antibiotic products. These advantages contribute to the large share of this product segment. The fluoroquinolones segment is expected to grow at the highest CAGR of 8.0% during the forecast period. Advantages such as higher efficacy at low concentrations, quick penetration through tissues, and the availability of variations in the route of administration result in the higher adoption of fluoroquinolones among end users. The Premixes segment accounted for the largest market share in 2020. Based on the mode of delivery, the global animal antimicrobials and antibiotics market is segmented into premixes, oral powders, oral solutions, injections, and other modes of delivery. In 2020, the premixes segment accounted for the largest share of 46.3% of the global animal antibiotics market. The large share of this segment can be attributed to the advantages of premixes, such as simplified mode of administration and lower instability and hygroscopicity of formulations. The injections segment is expected to witness the highest CAGR of 4.9% during the forecast period. Advantages such as immediate delivery of drugs and rapid onset of drug effects are expected to drive growth in this market. The food producing animal segment accounted for the largest market share in 2020. Based on animal type, the global animal antimicrobials and antibiotics market is categorized into food-producing animals and companion animals. In 2020, the food-producing animals segment accounted for the largest share of around 73.4%. This segment is also expected to register the highest CAGR of 3.9% during the forecast period. The large share of this segment is mainly due to the rising demand for animal-derived food products, increase in animal healthcare expenditure, and greater concerns about zoonotic diseases. Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=25161353 North America was the largest regional market for animal antibiotics market in 2020 The animal antimicrobials and antibiotics market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 30.3% of the global animal antimicrobials market. The large share of this region is mainly due to the increase in the region's animal population, rising demand for animal-derived food products, growth in pet insurance, and rising animal health expenditure compared to other regions. The Asia Pacific region is projected to grow at the highest CAGR of 5.4% during the forecast period. Factors such as the rapidly increasing animal population and rising demand for animal-derived food products are driving the growth of this market in the APAC. Some of the prominent players in the animal antimicrobials and antibiotics market are Boehringer Ingelheim (Germany), Zoetis Inc. (US), Elanco Animal Health (US), Merck & Co. Inc (US), Phibro Animal Health (US), Virbac (France), Vetoquinol S.A. (France), Ceva Santé Animale (France), Dechra Pharmaceuticals Plc (UK), Kyoritsu Seiyaku (Japan), Tianjin Ringpu (China), HIPRA (Spain), Zydus Animal Health (US), China Animal Husbandry (China), and Inovet (Belgium). Browse Related Reports: Animal Growth Promoters and Performance Enhancers Market by Product Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probioitcs & Prebiotics, Phytogenics), Animal (Poultry, Porcine, Livestock, Aquaculture) - Global Forecast to 2026https://www.marketsandmarkets.com/Market-Reports/animal-growth-promoters-performance-enhancers-market-137134167.html According to the new market research report "Digital X-ray Market by Portability (Fixed, Portable), Applications (General, Dental, Mammography, Cancer, Fluoroscopy), Technology (Direct, Computed), System (Retrofit, New), End Users, Price Range, Type, and Region - Global Forecast to 2026", published by MarketsandMarkets™, the market is expected to reach USD 16.4 billion by 2026 from an estimated USD 11.1 billion in 2021, at a CAGR of 8.1% from 2021 to 2026.
Browse in-depth TOC on "Digital X-ray Market" 230 – Tables 45 – Figures 280 – Pages Download PDF Brochure: :-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1164 The major factors driving the growth of this market include the increasing geriatric population and growth in disease incidence as well as favorable government regulations, investments, and initiatives. The advantages of digital X-ray systems have played a key part in their adoption; their speed and accuracy, as well as quick processing times, allow for significantly higher patient screening volumes than earlier. This has pushed companies to focus on product development and innovation. The direct radiography segment dominated the digital X-ray market in 2020 Based on technology, the market is segmented into direct radiography and computed radiography. The direct radiography segment commanded the largest share of the global market in 2020. The major benefit of DR-based systems over film and CR systems is that images are sent directly to a computer screen from the X-ray imaging plate, thereby eliminating the need to retrieve the image plate for processing images or taking a second X-ray shot. An effective dynamic range, better medical evaluation, superior and accurate image capture, reduced radiation exposure for patients and workers, flexibility in image management, improved patient throughput, superior evaluation of data and images, and lower operational costs are some of the other advantages of DR systems. Due to these advantages, the use of DR systems is on the rise. Portable digital X-ray systems are expected to register the highest CAGR during the forecasted period Based on portability, the digital X-ray market is segmented into fixed digital X-ray systems and portable digital X-ray systems. Fixed digital X-ray systems include floor-to-ceiling-mounted systems and ceiling-mounted systems, while portable digital X-ray systems include mobile X-ray systems and handheld X-ray systems. The portable digital X-ray systems are expected to grow with the highest CAGR during the forecasted period. Portable X-ray systems are light and can be transported to any desired location. These systems are especially useful in a variety of radiographic imaging set-ups, including intensive care units, cardiac care units, neonatal intensive care units, operating rooms, emergency rooms, and at the patient's bedside for critically ill patients or patients with mobility challenges. Request Sample Pages: :-https://www.marketsandmarkets.com/requestsampleNew.asp?id=1164 The retrofit digital X-ray systems segment dominated the digital X-ray market in 2020 The global digital X-ray systems market is divided into new and retrofit digital X-ray systems. The retrofit digital X-ray systems segment is expected to dominate the market during the forecast period. The large share of this segment can be attributed to the greater adoption of retrofit systems among end users due to their lower cost compared to new digital X-ray systems. Hospitals were the key end-users in the digital X-ray market in 2020 Based on end users, the X-ray market is segmented into diagnostic centers, hospitals, and dental care centers. Hospitals are expected to dominate the market during the forecast period. Hospitals constantly require advanced diagnostic systems that enable the screening and diagnosis of a large number of patients in a short time period. This is a key factor driving market growth. The general applications segment dominated the digital X-ray market by applications in 2020 Based on applications, the market is segmented into general radiography, dental applications, fluoroscopy, cancer, and mammography applications. The general radiography segment is expected to dominate this market during the forecast period. Growth in this market can be attributed to the increasing prevalence of target diseases, high demand for early diagnosis and diagnostic imaging, and technological advancements in the digital X-ray systems market. Speak to Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1164 Asia Pacific is expected to see the highest growth in the digital X-ray market by region The digital X-ray market is segmented into five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional market for digital X-ray systems, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. Growth in the digital X-ray market in the Asia Pacific is mainly driven by the growing geriatric population, particularly in Japan; increasing disposable incomes, allowing for greater affordability for advanced technologies; the rising prevalence of target diseases; and favorable government initiatives. Such factors help to drive the market for digital imaging systems in this region and draw foreign investments and partnerships. The digital X-ray market is dominated by Siemens Healthineers (Germany), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation (Japan), and Canon, Inc. (Japan). The other leading market players include Carestream Health (US), Shimadzu Corporation (Japan), Hologic Inc. (US), Agfa-Gevaert Group (Belgium), Samsung Medison (South Korea), and Konica Minolta (Japan). Browse Related Reports: Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, & Planar Scintigraphy), Application (Oncology, Cardiology & Neurology) & End user (Hospitals, Imaging Centers) - Global Forecasts to 2025 https://www.marketsandmarkets.com/Market-Reports/nuclear-imaging-equipment-market-98.html CBCT/Cone Beam Imaging Market by Application (Dental (Oral and Maxillofacial Surgery, Implantology, Orthodontics, Endodontics), Patient Position (Standing/Sitting, Seated, Supine), End User (Hospital, Private Practice) - Global Forecast to 2021https://www.marketsandmarkets.com/Market-Reports/cone-beam-imaging-market-226049013.html In-Vitro Diagnostics Market worth $96.0 billion by 2025 - Exclusive Report by MarketsandMarkets™2/24/2022 According to the new market research report "In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025", published by MarketsandMarkets™, the global IVD Market size is projected to reach USD 96.0 billion by 2025 from USD 84.5 billion in 2020, at a CAGR of 2.6% during the forecast period.
Browse in-depth TOC on "In-Vitro Diagnostics Market" 262 – Tables 53 – Figures 359 – Pages Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=703 Factors such as the increased adoption of PoC IVD devices, rising elderly population base, and the growing number of infectious diseases are expected to drive the growth of the IVD Market. By-products and services, the reagents & kits segment is expected to dominate the in vitro diagnostics market in 2020 Based on products and services, the IVD Market has been segmented into regents and kits, instruments, data management software and services. Within market, reagents and kits accounted for the largest share in 2020. The large share of this segment can be attributed to the superior quality of reagents enabling accurate diagnosis and thus, having high preference amongst the healthcare professionals. By end user, a point-of-care testing segment is expected to grow at the highest CAGR in the in vitro diagnostics market during the forecast period Based on end user, the market has been segmented into hospitals, laboratories, patient self-testing, academia, point-of-care -testing others. The point-of-care testing segment is estimated to have enormous growth due to rising availability of highly efficient PoC kits. Recently launched point-of-care devices offer a precise diagnosis of chronic diseases that has raised its adoption in laboratories. Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION: -https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=703 North America holds the largest share in the market in 2020, followed by Europe North America dominates the overall IVD Market based on region. This can be attributed to the rising geriatric population. Elderly population has comparatively weaker immunity and, therefore, is more susceptible to infections and other diseases. Furthermore, the regulatory scenario is quite stringent in the region that ensures the availability of defect-free IVD devices in the market that proves beneficial for market growth. The prominent players in the in vitro diagnostics market include Roche Diagnostics Limited (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMérieux (France), Diasorin (Italy), Ortho-Clinical Diagnostics (US), and Qiagen (Germany). Browse Related Reports: US In Vitro Diagnostics (IVD) Market by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology), Application (Infectious Diseases, Diabetes, Cancer, Cardiology), End User (Hospitals & Laboratories) & by Region - Forecast to 2020https://www.marketsandmarkets.com/Market-Reports/u-s-in-vitro-diagnostics-market-66290979.html According to the new market research report "Nerve Repair and Regeneration Market by Products (Nerve Conduits, Nerve Wraps, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, TENS, TMS), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) and Region - Global Forecast to 2025", published by MarketsandMarkets™, the global Nerve Repair and Regeneration Market size is projected to reach USD 9.7 billion by 2025 from USD 6.3 billion in 2020, growing at a CAGR of 9.1% from 2020 to 2025.
Browse in-depth TOC on "Nerve Repair and Regeneration Market" 142 – Tables 43 – Figures 167 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=883 The Growth in Nerve Regeneration Market is driven mainly by high incidence of nerve injuries, the growing prevalence of neurological disorders, and rising government support for neurologic disorder research. Neurostimulation and Neuromodulation Devices accounted for the largest share of the market, by product, in 2019 By product, the nerve repair market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment is segment is expected to grow at the highest growth rate during the forecast period. The large market share of this segment is driven mainly by rising government expenditure for neurologic disorders, and favorable reimbursement . By neurostimulation and neuromodulation application, internal neurostimulation and neuromodulation accounted for the largest market share in 2019 Based on the neurostimulation and neuromodulation application , the Nerve Regeneration Market is segmented the neurostimulation and neuromodulation devices market is segmented into internal neurostimulation and neuromodulation applications and external neurostimulation and neuromodulation applications. The internal neurostimulation and neuromodulation segment is estimated to register the highest CAGR during the forecast period. This can primarily be attributed to the increasing incidence of neurological disorders across the globe. By Biomaterials application, direct nerve repair/neurorrhaphy accounted for the largest market share in 2019 Based on application, the biomaterials market is segmented into direct nerve repair/neurorrhaphy, nerve grafting, and stem cell therapy. In 2019, the direct nerve repair segment accounted for the largest share of the market. This can be attributed to the increasing incidence of neurological disorders across the globe. Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=883 North America was the largest regional market for Nerve Repair Market in 2019 The Nerve Repair And Regeneration Market is segmented into five major regions, namely, Europe, North America, the Asia Pacific, Latin America, and Middle East & Africa. In 2019, North America accounted for the largest share of the Nerve Regeneration Market, followed by Europe. The rising incidence of neurological disorders, favorable reimbursement policies, and the strong presence of industry players in the region are the major factors driving the growth of the market in North America. Some of the major players operating in the global Nerve Repair And Regeneration Market include Medtronic, PLC. (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), AxoGen, Inc. (US), Baxter International, Inc. (US), LivaNova, PLC. (UK), Integra LifeSciences (US), Polyganics (Netherlands), NeuroPace, Inc. (US), Soterix Medical, Inc. (US), Nevro Corp (US), Synapse Biomedical, Inc. (US), Aleva Neurotherapeutics (Switzerland), Collagen Matrix, Inc. (US), KeriMedical (Switzerland), BioWave Corporation (US), NeuroSigma (US), tVNS Technologies GmbH(Germany), and GiMer Medical (Taiwan). Browse Related Reports: Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Autoimmune & Inflammatory), Cell Source (Adipose tissue, Bone Marrow, Placenta/Umbilical Cord) - Global Forecasts to 2026https://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html According to the new market research report "Research Antibodies and Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blotting, Flow Cytometry), Application (Proteomics, Drug Development), End User - COVID-19 Impact - Global Forecast to 2025", published by MarketsandMarkets™, the global market size is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period.
The growth is due to evolution of market owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and increasing R&D activity and expenditure in the life sciences industry. Fueled by the growing demand for personalized medicine and structure-based drug design, the global market is expected to witness significant growth in the coming years. Browse in-depth TOC on "Research Antibodies and Reagents Market" 220 – Tables 45 – Figures 278 – Pages Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793 The COVID-19 outbreak has boosted research activity due to efforts to understand the dynamics of the infection. We estimate that the major share of research antibody and reagent manufacturing, along with personalized medicine, will grow at a stable pace in the next five years. Due to the increase in research activity, both the availability of funding for research and the demand & manufacturing of reagents and antibodies are expected to grow. As companies after pandemic have scaled up their operations for testing and tracking the infection of COVID-19. This has given a chance for growth in profits for companies operating in the NGS and PCR markets. The growth in revenue is 5–7%, as COVID-19 testing has increased with the use of the latest technology of genetic and molecular testing. The shift in demand for research for COVID-19, neurobiology, and oncology has created a huge scope for testing solutions, such as western blotting, flow cytometry, ELISA, and drugs for researchers and laboratories. The antibodies segment is expected to grow at the highest CAGR during the forecast period Based on product, the research antibodies market is segmented into reagents and antibodies. The antibodies segment is expected to grow at highest CAGR in forecast period. This is due to the research-use antibodies offer high specificity and selectivity and are used ubiquitously in biochemical and medical research for protein-target identification, regulatory characterization, and discovery. The primary antibodies segment is accounts for the largest share of the research reagents market Based type, the research reagents market is segmented into primary antibodies and secondary antibodies. The primary antibodies segment held the largest share of the global research antibodies market in 2019. This segment is witnessing a strong growth due to the use of these antibodies in numerous types of assay formats. Their accuracy in biomarker detection and their high specificity and sensitivity are also driving their adoption The media & sera reagent is expected to account for the largest share of the market, by type, in 2019 Based type, the research antibodies and reagents market is segmented into media &sera, stains & dyes, fixatives, buffers, solvents, enzymes, probes and other reagents. The media & sera reagent segment held the largest share of the global research antibodies market in 2019. The large share of this segment is primarily attributed to the use of these components in all types of assays, cell cultures, and techniques. The western blotting segment is expected to account for the largest share of the market, by technology, in 2019 Based on technology, the research antibodies market is segmented into western blotting, flow cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and other technologies. Western blotting segment is expected to grow at highest CAGR in forecast periods (2020-2025). This is due to the high adoption of this technique in proteomic and genomic research. The results achieved are easy to interpret, unique, and unambiguous, making it suited for evaluating levels of protein expression in cells, monitoring fractions during protein purification, and comparing the expression of a target protein from various tissues. The pharmaceutical & biotechnology segment is expected to grow at the highest CAGR during the forecast period Based on end user, the research reagents market is segmented into the pharmaceutical & biotechnology companies, academic & research institutions and Contract Research Organizations. The growth of this segment is due to antibodies provide a gold standard for the detection of a biomolecule or a pathway and are even capable of detecting specific changes in potential drug targets. Additionally, highly specific reagents are used to measure pharmacokinetic parameters in the preclinical and clinical development of biological drugs. The increasing demand for personalized medicine and government initiatives in this sector are the key market drivers for this segment. Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION:-https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=94212793 The APAC market is expected to grow at the highest CAGR during the forecast period The Asia Pacific research reagents market is expected to grow at the highest CAGR from 2020 to 2025.The growth of this market is primarily due to growing proteomics and genomics research and increasing research funding, investments by pharmaceutical and biotechnology companies, and growing awareness of personalized therapeutics in the region. Also, high-growth countries, such as China, India, Japan, South Korea, Taiwan, Australia, and Singapore are the major contributors to the Asia Pacific research antibodies and reagents market. This region is expected to grow at the highest pace during the forecast period primarily due to growing proteomics and genomics research and increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and growing awareness about personalized therapeutics. The prominent market players are Thermo Fisher Scientific (US), Merck Group (Germany), Abcam plc (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), and BioLegend (US). Browse Related Reports: Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents, Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Laboratories, Pharma-Biotech Cos), Application - Global Forecasts to 2025 https://www.marketsandmarkets.com/Market-Reports/flow-cytometry-market-65374584.html According to the new market research report "Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, Reagents), Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), Enduser (Hospital, Diagnostic & Research Labs) - Global Forecast to 2025", published by MarketsandMarkets™, the ACR Test Market is projected to reach USD 2,103 million by 2025 from USD 987 million in 2020, at a CAGR of 16.3%.
Browse in-depth TOC on "Albumin and Creatinine Tests Market" 131 – Tables 32 – Figures 159 – Pages Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=156696568 The growth of the global albumin & creatinine tests market is driven by factors such as the growing prevalence of kidney disorders, the rising adoption of POC diagnostics, and the increasing prevalence of chronic conditions. The dipsticks & kits products segment accounted for the largest share of the ACR Tests Market, by product segment, in 2019 Based on product, the albumin and creatinine tests market is segmented into dipsticks & kits, analyzers, cartridges, and reagents & other consumables. In 2019, the dipsticks & kits segment accounted for the largest share in this market. The frequent purchase of these products compared to instruments like analyzers and cartridges and the increasing use of kit-based rapid techniques for albumin & creatinine tests drive market growth. Urine Tests segment to register the highest growth rate during the forecast period Based on type, the albumin & creatinine tests market is segmented into urine tests and blood & serum creatinine tests. In 2019, urine tests accounted for the largest share in this market. Factors such as the rapid growth in the diagnostics segment and the increasing demand for rapid and easy-to-use urine tests drive the growth of this segment. Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION: - https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=156696568 North America is the largest regional market for albumin & creatinine tests market The global ACR Test Market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest share in the global market. The large share of this regional segment can primarily be attributed to the growth in demand for rapid urine tests, increasing prevalence of chronic conditions leading to various kidney diseases, rising government initiatives, and growing geriatric population. The major players operating in this ACR Tests Market are Thermo Fisher Scientific, Inc. (US), Roche Diagnostics (Switzerland), PromoCell GmbH (Germany), Abbott Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Randox Laboratories (UK), FUJIFILM Wako Pure Chemical Corporation (Japan), Abbexa Ltd. (UK), ACON Laboratories, Inc. (US), Arbor Assays Inc. (US), ARKRAY Global Business Inc. (Japan), Aviva Systems Biology (US), Axxora, LLC (UK), BioAssay Systems (US), Nova Biomedical (US), Quantimetrix Corporation (US), RayBiotech Inc. (US), Sekisui Diagnostics PEI Inc. (US), Teco Diagnostics (US), Tulip Diagnostics (India), ulti med Products GmbH (Germany), and URIT Medical Electronic Co., Ltd. (China). Browse Related Reports: Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024 https://www.marketsandmarkets.com/Market-Reports/urinalysis-systems-market-153479294.html Particle Size Analysis Market worth $492 million by 2026 - Exclusive Report by MarketsandMarkets™2/15/2022 According to the new market research report "Particle Size Analysis Market by Technology (Laser Diffraction, DLS, Imaging, Coulter Principle, Sieving, Nanoparticle Tracking), Dispersion (Wet, Dry, Spray), Enduser (Pharma-biotech, Cosmeceutical, Chemicals, Food, Academia) - Global Forecasts to 2026", published by MarketsandMarkets™, the market size is projected to reach USD 492 million by 2026 from USD 371 million in 2021, growing at a CAGR of 5.8%.
Browse in-depth TOC on "Particle Size Analysis Market" 116 – Tables 37 – Figures 209 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74084833 Increasing research activities in the field of nanotechnology, increasing investments in pharmaceutical R&D, and stringent regulatory guidelines for product quality across industries fueling the growth of the market. Moreover, increasing government support for nanotechnology research and rapidly growing pharmaceutical industry in emerging countries, are some of the other major factors driving the growth of this market. The laser diffraction segment accounted for the largest share of the particle size analysis market, by technology, in 2020 Based on technology, the market is segmented into laser diffraction, dynamic light scattering, imaging, coulter principle, nanoparticle tracking analysis, sieve analysis and other technologies. The laser diffraction segment accounted for the largest share of this market in 2020, driven by growing initiatives to create awareness about laser diffraction, increasing trainings conducted by companies, increasing R&D expenditure in the pharma and biotech sectors, and rising food safety concerns. Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=74084833 Dynamic imaging to dominate the imaging market during the forecast period Based on type, the imaging market is segmented into two major types—dynamic imaging, and static imaging. Factors such as high-quality/resolution images, better image recognition, user friendliness, individual sample measurement, and high speed analysis are driving the growth of the dynamic imaging segment. Nanoparticle Tracking Analysis (NTA) to register the highest growth over the forecast period among particle size analysis technologies The Nanoparticle Tracking Analysis (NTA) segment is expected to register the highest growth over the forecast among the particle size analysis technologies market over the forecast period. The significant growth of this segment is attributed to advanced applications of these particle size analyzers and growing research activities in the field of nanotechnology. In addition, NTA is mainly used in biopharma and biotech applications and with increasing R&D activities in the biopharmaceutical industry, this market segment is expected to show growth during the forecast period. Speak to Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=74084833 North America to dominate the particle size analysis market during the forecast period The particle size analysis industry is segmented into five regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North American region accounted for the largest share of this market in 2020. Presence of a large customer base in the region, relatively low energy prices in the US market as compared to other competitive nations such as the UK and Japan are encouraging the growth of end-use markets (such as mining, minerals, chemicals, petroleum) in the US. Moreover, significant funding for nanotechnology development and strict industrial regulations for particle size analysis for pharmaceutical drugs and food products with respect to drug development and quality control are some of the major factors driving the growth of the life science instrumentation sector in North America. The major players operating in the global particle size analysis market include Malvern Panalytical Ltd. (UK), HORIBA (Japan), Beckman Coulter, Inc. (US), Anton Paar GmbH (Austria), Aimsizer (China), Bettersize Instruments Ltd. (China), Brookhaven Instruments (US), Fritsch GmbH (Germany), LS Instruments (Switzerland), METLLER TOLEDO (US), Micromeritics Instrument Corporation (US), Microtrac Retsch GmbH (Germany), Shimadzu Corporation (Japan), Sympatec GmbH (Germany), and TSI (US), among others. Urology Devices Market worth $46.4 billion by 2026 - Exclusive Report by MarketsandMarkets™2/14/2022 According to the new market research report "Urology Devices Market by Product ((Dialysis, Endoscopes, Lasers, Lithotripsy, Robotic System), (Guidewires, Catheters, Stents)), Application(Kidney Diseases, Urological Cancer, BPH), End User(Hospital, Dialysis Center, Homecare) - Global Forecast to 2026", published by MarketsandMarkets™, the market is projected to reach USD 46.4 billion by 2026 from USD 38.0 billion in 2021, at a CAGR of 4.1%.
Browse in-depth TOC on "Urology Devices Market" 122 – Tables 36 – Figures 198 – Pages Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173062212 The rising incidence and prevalence of urological conditions drives growth in the urology devices market, growing preference for minimally invasive procedures, and the growing number of hospitals and investments in endoscopy and laparoscopy facilities are among the other factors. Emerging economies such as China and Japan are providing lucrative opportunities for the players operating in the market. The instruments segment accounted for the largest share of the urology devices market, by product segment, in 2020 Based on product, the market is segmented into instruments and consumables & accessories. The instruments segment accounted for the largest share of the market in 2020. This segment includes dialysis devices, endoscopes, laser and lithotripsy devices, robotic systems, endovision and imaging systems, insufflators, endoscopy fluid management systems, and urodynamic systems. The dialysis devices segment accounted for the largest share of the urology instruments market in 2020. The large share of this segment can be attributed to the growing patient pool of CKD due to the rising geriatric population. Urological cancer and BPH segment to register the highest growth rate during the forecast period The urology devices market is segmented into kidney diseases, urological cancer and BPH, pelvic organ prolapse, and other applications based on application. In 2020, the urological cancer and BPH segment accounted for the highest growth rate. This can be attributed to the rising incidence of urological cancers coupled with the growing number of cancer-related surgeries. The hospitals, ASCs, and clinics segment accounted for the largest share of the urology devices market, by end user segment, in 2020 Based on end users, the market is segmented into hospitals, ASCs, and clinics; dialysis centers; and home care settings. In 2020, the hospitals, ASCs, and clinics segment accounted for the largest share of the market. The improving healthcare infrastructure in developing countries such as India, the rising number of target procedures, and the rising number of surgeries are the major factors driving this segments growth. Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=173062212 North America is the largest regional market for urology devices market the market is segmented into five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the urology devices market. The large share of this region can be attributed to the increasing healthcare expenditure, highly developed healthcare systems in the US and Canada, and increasing prevalence of chronic and lifestyle conditions. The major players operating in this urology devices market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), Olympus Corporation (Japan), B. Braun Melsungen AG (Germany), Stryker Corporation (US), KARL STORZ (Germany), Cook Medical (US), Intuitive Surgical (US), Medtronic plc (Ireland), Cardinal Health (US), Teleflex Incorporated (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Balton Sp. z o.o. (Poland), Dialife SA (Switzerland), Maxer Endoscopy GmbH (Germany), Vimex Sp. z o.o. (Poland), Amsino International, Inc. (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Medispec (US), Medical Technologies of Georgia (Georgia), EndoMed Systems GmbH (Germany), Hunter Urology (England), J and M Urinary Catheters LLC (US), and Ribbel International Limited (India). Browse Related Reports: Urinary Catheters Market by Product (Indwelling, Intermittent, External), Type (Coated, Uncoated), Application (Urinary Incontinence, Benign Prostate Hyperplasia, General Surgery), Usage (Male, Female), End Users (Hospitals) - Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/urinary-catheter-market-132934629.html |
AuthorWe are providing and consulting the healthcare Industry Research Report. Archives
March 2022
Categories |